Skip to main content

Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma.

Publication ,  Conference
Desjardins, A; Randazzo, D; Chandramohan, V; Peters, K; Johnson, MO; Threatt, S; Herndon, J; Boulton, S; Healy, P; Lipp, E; Fecci, P ...

Duke Scholars

Location

The West Coast of Norway

Conference Name

Oral presentation at the 22nd International Conference on Brain Tumor Research & Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Randazzo, D., Chandramohan, V., Peters, K., Johnson, M. O., Threatt, S., … Bigner, D. (n.d.). Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma. Presented at the Oral presentation at the 22nd International Conference on Brain Tumor Research & Therapy, The West Coast of Norway.
Desjardins, Annick, Dina Randazzo, V. Chandramohan, Katherine Peters, Margaret O. Johnson, Stevie Threatt, James Herndon, et al. “Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma.,” n.d.
Desjardins A, Randazzo D, Chandramohan V, Peters K, Johnson MO, Threatt S, et al. Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma. In.
Desjardins A, Randazzo D, Chandramohan V, Peters K, Johnson MO, Threatt S, Herndon J, Boulton S, Healy P, Lipp E, Fecci P, Sampson J, Friedman A, Friedman H, Ashley D, Bigner D. Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma.

Location

The West Coast of Norway

Conference Name

Oral presentation at the 22nd International Conference on Brain Tumor Research & Therapy